Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Parenteral
Solubilizers
Film Formers & Plasticizers
Lubricants & Glidants
Emulsifying Agents
Thickeners and Stabilizers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
91
PharmaCompass offers a list of Flunisolide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Flunisolide manufacturer or Flunisolide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Flunisolide manufacturer or Flunisolide supplier.
PharmaCompass also assists you with knowing the Flunisolide API Price utilized in the formulation of products. Flunisolide API Price is not always fixed or binding as the Flunisolide Price is obtained through a variety of data sources. The Flunisolide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Syntaris manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Syntaris, including repackagers and relabelers. The FDA regulates Syntaris manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Syntaris API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Syntaris manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Syntaris supplier is an individual or a company that provides Syntaris active pharmaceutical ingredient (API) or Syntaris finished formulations upon request. The Syntaris suppliers may include Syntaris API manufacturers, exporters, distributors and traders.
click here to find a list of Syntaris suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Syntaris DMF (Drug Master File) is a document detailing the whole manufacturing process of Syntaris active pharmaceutical ingredient (API) in detail. Different forms of Syntaris DMFs exist exist since differing nations have different regulations, such as Syntaris USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Syntaris DMF submitted to regulatory agencies in the US is known as a USDMF. Syntaris USDMF includes data on Syntaris's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Syntaris USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Syntaris suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Syntaris as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Syntaris API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Syntaris as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Syntaris and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Syntaris NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Syntaris suppliers with NDC on PharmaCompass.
Syntaris Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Syntaris GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Syntaris GMP manufacturer or Syntaris GMP API supplier for your needs.
A Syntaris CoA (Certificate of Analysis) is a formal document that attests to Syntaris's compliance with Syntaris specifications and serves as a tool for batch-level quality control.
Syntaris CoA mostly includes findings from lab analyses of a specific batch. For each Syntaris CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Syntaris may be tested according to a variety of international standards, such as European Pharmacopoeia (Syntaris EP), Syntaris JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Syntaris USP).
